105 research outputs found
A Study on the Development of the Safety Evaluation Index for Improving the Safety of a Passenger Ship
The main factors of causing marine accidents are the seafarer, vessel, and traffic environments. Except for the accidents caused by natural disasters, most of the marine accidents occur when there is a deficiency in one or more of the above factors. The major passenger ship accidents in domestic such as MV Nam-Young accidents, the MV Seohae accident were caused by the defects of these factors. Although the safety management system in Korea has been improved since then, there has been a consistent need for the betterment of the system for the prevention of continuing accidents such as MV Sewol ferry disaster in 2014.
Especially, due to its nature, the influence of the passenger ship accident is critical, despite the fact that the number of passenger ship accident is only 2.0% of the whole marine accidents.
To prevent these accidents, passenger ships must secure seaworthiness before its operation. However, safety management system for evaluating seaworthiness for passenger ships had not yet been developed.
In this study, safety management system for passenger ships was proposed. To develop the system, subtleties of different criteria such as ship stability, seafarer's training, regulations for safety management, and management of passengers were taken into account.
Also, Safety Evaluation Index was estimated by carefully analyzing the passenger ship accidents since 1962' and was used to evaluate the system. Hull, seafarer's training, regulations for safety management, passenger/cargo management, and other factors were considered and specific criteria for each factor were defined for the evaluation.
Furthermore, Safety Evaluation Index was applied to the major catastrophes of passenger ships, such as Sinking of the MV Nam-Young 1970, MV Seohae in 1993, MV Sewol in 2014 and the reliability of the proposed methods was reviewed. Through the estimation of Safety Evaluation Index, it would be possible to assess the safety management level of the passenger ships, which will eventually be used for establishing the regulations in regards to preventing accidents of passenger ships.List of Tables β
³
List of Figures β
΅
Abstract β
Ά
μ 1 μ₯ μ λ‘ 1
1.1 μ°κ΅¬μ λ°°κ²½ λ° λͺ©μ 1
1.2 μ°κ΅¬ λ°©λ² λ° λ΄μ© 6
μ 2 μ₯ κ΅λ΄ μ¬κ°μ μ νν© λ° ν΄μ μ¬κ³ λΆμ 10
2.1 κ΅λ΄ μ¬κ°μ μ μ΄ν νν© 10
2.2 μ¬κ°μ μ¬κ³ λΆμ(1962εΉ΄-2015εΉ΄) 17
2.2.1 μ¬κ°μ μ¬κ³ λΆμ 17
2.2.2 μ¬κ³ μ νλ³ μ¬κ°μ μ¬κ³ λΆμ 20
2.2.3 μ¬κ³ μμΈλ³ μ¬κ°μ μ¬κ³ λΆμ 31
μ 3 μ₯ λν μ¬κ°μ μ¬κ³ μ λ°λ₯Έ μμ κ΄λ¦¬μ²΄κ³μ λ³ν 32
3.1 λ¨μνΈμ μ¬κ³ λΆμ 32
3.1.1 λ¨μνΈμ μ¬κ³ κ°μ 32
3.1.2 λ¨μνΈμ μ¬κ³ μμΈ 34
3.1.3 μ¬κ³ ν μμ κ΄λ¦¬μ λμ λ³ν 36
3.2 μν΄νΌλ¦¬νΈμ μ¬κ³ λΆμ 37
3.2.1 μν΄νΌλ¦¬νΈμ μ¬κ³ κ°μ 37
3.2.2 μν΄νΌλ¦¬νΈμ μ¬κ³ μμΈ 38
3.2.3 μ¬κ³ ν μμ κ΄λ¦¬μ λμ λ³ν 40
3.3 μΈμνΈμ μ¬κ³ λΆμ 43
3.3.1 μΈμνΈμ μ¬κ³ κ°μ 43
3.3.2 μΈμνΈμ μ¬κ³ μμΈ 44
3.3.3 μ¬κ³ ν μμ κ΄λ¦¬μ λμ λ³ν 47
3.4 λν μ¬κ°μ μ¬κ³ μ λ°λ₯Έ μμ κ΄λ¦¬μ²΄κ³μ λ³ν 51
μ 4 μ₯ μ¬κ°μ μ μμ κ΄λ¦¬νκ°μ§νμ κ°λ° 53
4.1 μμ κ΄λ¦¬νκ°μ§νμ κ΅¬μ± 53
4.2 μ¬κ°μ μ¬κ³ μμΈ λΆλ₯μ²΄κ³ λΉκ΅ λΆμ 55
4.2.1 ν΄μμμ μ¬νμ 55
4.2.2 ν΄μκ²½λΉμμ λ³ΈλΆ 57
4.2.3 μΌλ³Έ ν΄μ보μμ² 58
4.2.4 μκ΅ ν΄μμ¬κ³ μ‘°μ¬κ΅ 59
4.2.5 ν΄μμ¬κ³ μμΈ λΆλ₯ λΉκ΅ λΆμ 60
4.3 μμ κ΄λ¦¬μ²΄κ³ νκ° μμ λμΆ 62
4.3.1 μ λ°μμ 62
4.3.2 μ μ κ΅μ‘ 64
4.3.3 μμ κ΄λ¦¬μ λ 65
4.3.4 μΉκ°/νλ¬Ό κ΄λ¦¬ 66
4.3.5 κΈ° ν 67
4.4 νκ°μ§ν μ립μ μν κ°μ€μΉ μ°μ 68
4.4.1. ν΄μμ¬κ³ μ λ° λ³μμ μ°μ 68
4.4.2. μμ κ΄λ¦¬μ λ ν립 λ³μμ μ°μ 74
4.5 μμ κ΄λ¦¬νκ°μ§νμ νκ°ν μμ± 76
μ 5 μ₯ μ¬κ°μ μ¬κ³ μ λν μμ κ΄λ¦¬νκ°μ§ν μ μ© 80
5.1 μ¬κ°μ μ¬κ³ μ λν νκ°μ§ν κ²μ¦ 80
5.1.1 μ¬κ³ μ¬λ‘λ³ κ΅¬μ‘° λΆμ 80
5.1.2 μ¬κ³ μ¬λ‘λ³ κ°μ€μΉ μ°μ 81
5.2 λ¨μνΈμ μ μ©ν μμ κ΄λ¦¬νκ°μ§ν 84
5.3 μν΄νΌλ¦¬νΈμ μ μ©ν μμ κ΄λ¦¬νκ°μ§ν 88
5.4 μΈμνΈμ μ μ©ν μμ κ΄λ¦¬νκ°μ§ν 93
5.5 μ¬κ°μ μ¬κ³ μ λν μμ κ΄λ¦¬νκ°μ§νμ μ’
ν©λΆμ 97
μ 6 μ₯ κ²° λ‘ 100
μ°Έκ³ λ¬Έν 102
λΆ λ‘ 105
κ°μ¬μ κΈ 117Maste
Prediction of the Catalyst Life Span in Bisphenol A Reactor through Cumulative Exposure of Catalyst Poison
νμλ
Όλ¬Έ(μμ¬) -- μμΈλνκ΅λνμ : 곡νμ λ¬Έλνμ μμ©κ³΅νκ³Ό, 2022.2. μ΄μ’
λ―Ό.νν곡μ₯μμ μ΄λ§€ λ°μ 곡μ μ 곡μ₯μ μμ°μ±, μμ¨, λ° νμ§μ κ²°μ μ§λ ν΅μ¬ 곡μ μ΄λ€. μμ μ μΈ μμ°κ³Ό νμ§μ μν΄μλ μ΄λ§€μ μλͺ
μ μ€λ μ μ§νμ¬ λ°μ 곡μ μ λ³λμ μ΅μνν νμκ° μλ€. μ΅κ·Ό Bisphenol A 곡μ μμλ μμΈν€ μλ£ μ€μ μ΄λ§€λ
μν μ λ©νμ¬ μ±λΆμ μ€μ΄λ νλμ νκ³ μλ€. μ΄μ λ©νμ¬ ν¨λμ λ°λ₯Έ λ°μ 곡μ μ±λ₯μ λͺ¨μ¬νμ¬ λ©νμ¬ μ κ° λͺ©ν λ° μ΄λ§€ κ΅μ²΄ κ³ν κ΄λ¦¬μ νμν κΈ°μ΄ μλ£λ₯Ό ν보νκ³ μ νλ€. κ·Έλ¬λ νμ¬ μμ μ λ©νμ¬ ν¨λλ§μΌλ‘ μ₯κΈ°κ°μ κ±Έμ³ μ§νλλ μ΄λ§€ λΉνμ±νλ₯Ό μ€λͺ
νκΈ°λ μ΄λ ΅λ€. λ°λΌμ νμ¬κΉμ§ λ°μκΈ°μ μ μ
λ λ©νμ¬μ μ΄λμ μ΄λ§€λ
μ λμ λ
ΈμΆ μ΄λ ₯μΌλ‘μ¨ μ€λͺ
λ³μλ‘ νμ©νμ¬ μ΄λ§€ λΉνμ±νλ₯Ό μ€λͺ
ν΄ λ³΄κ³ μ νμλ€. μ΄λ§€μ νμ±μ μ§μ μΈ‘μ ν μ μμ΄μ λ°μκΈ° μ νμ¨μ μ’
μλ³μλ‘ μ μ νκ³ λ°μκΈ° μ νμ¨μ μ€λͺ
λ³μμ μ΄λ§€ λΉνμ±ν λ³μλ₯Ό μ‘°ν©νμ¬ κΈ°κ³νμ΅(PLS, SVM, ANN)μ μννμλ€. μ΄λ§€ λΉνμ±ν μμ λ³μλ λ©νμ¬μ΄ μ΄λ§€μ λ°μνλ λ° μν₯μ λ―ΈμΉλ μ¨λμ μ λ, μμΈν€ μΈμλ€μ μ‘°ν©νμ¬ ν보ꡰμ λ§λ€μλ€. μ€ν κ²°κ³Ό λ©νμ¬ λμ μ λ λ³μλ₯Ό μ¬μ©ν λͺ¨νμ μ€μ°¨κ° κ°μ₯ μμμΌλ©° λΉμ ν νκ· λͺ¨νμ μ νλκ° μ ν νκ· λͺ¨νλ³΄λ€ λμλ€. μμνλ μ¨λμ μν₯μ λΆμ°μ΄ μ κΈ° λλ¬Έμ μ΄λ§€ λΉνμ±νλ₯Ό μ μλ―Ένκ² μ€λͺ
ν μ μμλ€. λ©νμ¬ ν¨λμΌλ‘ λμ κ°μ λͺ¨μμ€νν κ²°κ³Ό 250ppmμμ 70ppmμΌλ‘ μ κ° μ κΈ°μ‘΄ 20κ°μμμ 70κ°μλ‘ λ°μκΈ° μ νμ¨μ΄ μ μ§λ κ²μΌλ‘ μμΈ‘νμλ€.In chemical plants, the catalytic reaction process is a key factor that determines the productivity, yield, and quality of the plant. For stable production and quality, it is necessary to minimize fluctuations in the reaction process by maintaining the life of the catalyst for a long time. Recently, in the Bisphenol A process, activities are underway to reduce methanol components that act as a catalyst poison in acetone. Therefore, by simulating the reaction process performance according to the methanol content, basic data necessary for the management of the methanol reduction goal and catalyst replacement plan are secured. However, it is difficult to explain the degree of catalyst deactivation over a long period of time only with the methanol content at this point. Therefore, the total amount of methanol flowed into the reactors so far, which is a cumulative exposure history of the catalyst poison, was used as an explanatory variable to explain catalyst deactivation. Since the activity of the catalyst cannot be measured directly, the reactor conversion rate was selected as a dependent variable, and machine learning (PLS, SVM, ANN) was performed by combining the explanatory variable of the reactor conversion rate and the catalyst deactivation variable. As for the expected catalyst deactivation variable, a candidate group was created by combining the temperature, flow rate, and acetone that influence methanolβs reaction with the catalyst. As a result of the experiment, the error of the model using the methanol cumulative flow rate variable was the smallest, and the accuracy of the nonlinear regression model was higher than that of the linear regression model. The effect of the temperature could not significantly explain catalyst deactivation because the variance was small. As a result of simulating the cumulative value with methanol content, it was predicted that the reactor conversion rate would be maintained from 20 to 70 months if it was reduced from 250 ppm to 70 ppm.I. μλ‘ 1
1.1 μ°κ΅¬μ λ°°κ²½ λ° λͺ©μ 1
1.2 μ°κ΅¬ λ²μμ λ°©λ² 3
1.2.1 Bisphenol A μμ° κ³΅μ 3
1.3 μ μ½ μ¬ν 6
1.4 μ°κ΅¬ λ΄μ© 8
1.5 λ
Όλ¬Έμ κ΅¬μ± 9
II. μ΄λ‘ μ λ°°κ²½ λ° κ΄λ ¨ μ°κ΅¬ 10
2.1 μ΄λ‘ μ λ°°κ²½ 10
2.1.1 μ΄λ§€ λΉνμ±ν 10
2.1.2 κΈ°κ³νμ΅ 13
2.2 κ΄λ ¨ μ°κ΅¬ 16
2.2.1 μ΄λ§€ λΉνμ±ν 16
2.2.2 μ±λ₯ λͺ¨νν 19
III. μ°κ΅¬ κ²°κ³Ό 22
3.1 λ°μ΄ν° μ μ²λ¦¬ 22
3.1.1 μλ£ μμ§ 22
3.1.2 λ°μκΈ° κ³΅κΈ μ λ μΆμ 22
3.1.3 λ°μκΈ° μ
ꡬ μ‘°μ± 24
3.1.4 μλ£ λΆμ κ²°κ³Ό κ²μ 25
3.2 μμΈ‘ λͺ¨ν 26
3.2.1 μμ λ³μ μ μ 26
3.2.2 λ³μ μ ν 27
3.2.3 λͺ¨ν μ립 31
3.2.4 λ³μ/λͺ¨ν νκ° κ²°κ³Ό 32
3.3 λͺ¨μ μ€ν 36
3.3.1 μ΄μ 쑰건μ λ°λ₯Έ μλͺ
36
3.3.2 μ΄μ λ°μκΈ° μμ¬ μλͺ
μμΈ‘ 41
3.3.3 μλͺ
μ°μ₯μ λ°λ₯Έ μμ ν¨κ³Ό 43
IV. κ²°λ‘ λ° κ³ μ°° 46
μ°Έκ³ λ¬Έν 49
Abstract 51μ
Application Plan of Geomorphological Classification Map for National LTER - Case Study of Mt. Halla -
TNF-Ξ± and IL-10 gene polymorphisms in inflammatory bowel disease
νμλ
Όλ¬Έ(λ°μ¬)--μμΈλνκ΅ λνμ :μνκ³Ό λ΄κ³Όνμ 곡,2002.Docto
Globalization of National Economic Regulation -WTO-Norm as criterion in the Control of Bureaucracy?-
In our age of globalization, the World Trade Organization (WTO) exercises
extensive powers over national economic regulation policy, both implicitly and
explicitly. However, there have been few legal analyses of the constitutional
legitimacy of its harmonization process in Korea. This article analyses the
legitimacy issues from the viewpoint of the rule of law(Rechtsstaat) and the
principle of democracy in the Korean constitutional and administrative law and
reviews the compatibility of WTO-order with the national public interest related
to economic regulation.
Recently, the Supreme Court handed down a ruling repealing the Junlabuk-do
provincial assembly's ordinance, which sanctioned the preferential use of domestic
products in school cafeterias. This ruling is used in this article as a case study
to show how far WTO-norm can influence national regulation decision and how
the compliance with the WTO-norm could be misconstrued in several respects.
The court stated that the ordinance violated the governing principle of the GATT
1994 Article III (national treatment), but the court did not explain whether and
how it permitted the judicial enforceability of WTO agreements in the national
order. This article criticizes the courts decision, because it did not consider the
nature of the WTO-norm in relation to the principles of reciprocity and the
attitude of the Korean Congress, which did not declare that the WTO-norm was
directly applicable to the country.
It cannot be denied, on the other hand, that the government needs to keep..
ν¬λλΉμ κ³ΌλΉ ν‘μ μ΄μ§ ν¨κ³Όμ μ카보μ¦κ° λ―ΈμΉλ μν₯
νμλ
Όλ¬Έ(μμ¬)--μμΈλνκ΅ λνμ :μνκ³Ό λ΄κ³Όνμ 곡,2000.Maste
μμ₯μ Ξ²Pix isoformμ ν΄λ‘λ λ° κΈ°λ₯μ°κ΅¬
Thesis (master`s)--μμΈλνκ΅ λνμ :μλͺ
κ³ΌνλΆ,2001.Maste
μ€κΈ°μΈν¬ μΆμ λ° λκ²½μ μΉλ£μ νμ©λλ κΈ°λ₯μ± λ¬΄κΈ° λλ Έμ μμ κ°λ°
νμλ
Όλ¬Έ (λ°μ¬)-- μμΈλνκ΅ λνμ : ννμ물곡νλΆ μλμ§νκ²½ ννμ΅ν©κΈ°μ μ 곡, 2013. 2. ννν.During the last decade, various functional nanostructured materials with interesting optical, magnetic, mechanical, and chemical properties have been extensively applied to biomedical areas including imaging, diagnosis, and therapy. In particular, interdisciplinary collaborative research between material science and biomedicine enabled nanomaterials to translate the medical issues and application to clinical trials. Cellular therapies by the administration of therapeutic cells such as stem cells or immune cells benefit greatly from the inclusion of nanomaterials to achieve high-resolution tracking of the cells. Another application of nanomaterials is as intrinsic chemotherapeutic agents. Long-term cell tracking can be realized by producing highly sensitive nanoparticles or by the control of particle-cell interactions. Engineering physical and chemical properties of nanoparticles - such as size, surface, and composition, enables to obtain optimized therapeutic potentials at target tissues with minimal toxicity.
Firstly, hollow manganese oxide core and mesoporous silica coated (HMnO@mSiO2) nanoparticles were fabricated for highly efficient T1 magnetic resonance imaging (MRI) contrast agent for labeling and MRI tracking of stem cells. These nanoparticles have been designed to enable optimal access of water molecules to core Mn ions combined with the large surface area-to-volume ratio, exhibiting much higher r1 relaxivity over other existing MnO nanoparticle-based MRI contrast agents. Adipose-derived mesenchymal stem cells (MSCs) were efficiently labeled using electroporation, and detected on T1-weighted MR images in vitro. Intracranial grafting of HMnO@mSiO2-labeled MSCs enabled serial MR monitoring of cell transplants over a prolonged period of time.
Secondly, computed tomograpy (CT) cell tracking methods with gold nanoparticles were developed. CT cell tracking has been known to be very difficult due to its low sensitivity. Herein, 40 nm citrate stabilized gold nanoparticles were readily complexed with poly-L-lysine (PLL), which were then successfully used to label human mesenchymal stem cells (hMSCs). More importantly, gold nanoparticles labeling did not impair cellular viability, proliferation, and differentiation. Labeled hMSCs were visualized in vitro and tracked in vivo using micro-CT and their detection limit revealed to be ~ 10,000 cells/ΞΌl in vivo. This study represents, to the best of our knowledge, one of the first attempts to develop CT cell tracking, and can be applied in CT image-guided interventions and fluoroscopic procedures commonly used for injection of molecular and cellular therapeutics.
Finally, the protective effects of ceria nanoparticles against ischemic stroke were studied. Reactive oxygen species (ROS) are a major cause of ischemic brain injury, and ceria nanoparticles are known to exhibit potent free radical scavenging activity. Discrete and uniform 3 nm-sized ceria nanoparticles which were colloidally very stable and tissue permeable were synthesized. These nanoparticles were successfully demonstrated to protect against ischemic stroke in living animals which has been done for the first time. Targeting infarct site after intravenous injection, optimal dose of ceria nanoparticles (0.5 and 0.7 mg/kg) significantly reduced infarct volume and ischemic cell death in vivo. These protective effects of ceria nanoparticles in in vivo model were mediated by scavenging of ROS and a decrease in apoptosis.Chapter 1 Nanomaterials in Translational Medicine: Therapeutic Applications and Developments--------------1
1.1 Introduction----------------------------------1
1.2 Nanomaterials to track stem cell therapies-----5
1.2.1 The importance of stem cell tracking----------5
1.2.2 Stem cell imaging modalities-----------------9
1.2.3 Various nanoparticles for stem cell tracking---13
1.2.4 Cell labeling techniques---------------------22
1.2.5 Applications of stem cell tracking------------------27
1.3 Nanomaterials as chemotherapeutic agents--33
1.3.1 Nanoparticles as anticancer agents--------- 34
1.3.2 Radical scavenging nanomaterials---------- 38
1.3.2.1 Oxidative stress in biological systems ------38
1.3.2.2 Fullerenes and fullerene derivative---------- 42
1.3.2.3 Ceria nanoparticles as potential antioxidants-45
1.3.2.4 Biological effects of ceria nanoparticles in vitro and in vivo------------------------------------------- 48
1.4 References--------------------------------54
Chapter 2 Mesoporous Silica-Coated Hollow Manganese Oxide Nanoparticles as Positive T1 Contrast Agents for Labeling and MRI Tracking of Adipose-Derived Mesenchymal Stem Cells------------------------------68
2.1 Introduction---------------------------------68
2.2 Experimental Section------------------------72
2.3 Results and Discussion---------------------85
2.4 Conclusion--------------------------------110
2.5 References--------------------------------111
Chapter 3 Micro-CT Imaging of Human Mesenchymal Stem Cells Labeled with Gold Nanoparticles------------119
3.1 Introduction--------------------------------119
3.2 Experimental Section-----------------------122
3.3 Results and Discussion--------------------134
3.4 Conclusion--------------------------------155
3.5 References--------------------------------156
Chapter 4 Ceria Nanoparticles that can Protect against Ischemic Stroke-------------------------------------- 161
4.1 Introduction--------------------------------161
4.2 Experimental Section-----------------------163
4.3 Results and Discussion--------------------180
4.4 Conclusion--------------------------------211
4.5 References--------------------------------212
Bibliography------------------------------------------217
κ΅λ¬Έ μ΄λ‘ (Abstract in Korean)-------------------------225Docto
μ±μΈκΈ°μ λ°μν λͺ¨μΌλͺ¨μΌλ³μ μμνΉμ±κ³Ό EDAS (encephalo-duro-arterio-synangiosis) μμ μ±μ μ λν μ°κ΅¬
νμλ
Όλ¬Έ(μμ¬)--μμΈλνκ΅ λνμ :μνκ³Ό μ κ²½μΈκ³Όνμ 곡,1999.Maste
- β¦